Tags

Type your tag names separated by a space and hit enter

In reply to 'Role of sodium restriction in recurrent stone formers with hyperoxaluria'.
Am J Kidney Dis. 2014 Sep; 64(3):478-9.AJ

Authors+Show Affiliations

Shahid Beheshti University of Medical Sciences, Tehran, Iran.New York University School of Medicine, New York, New York.Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

25150856

Citation

Noori, Nazanin, et al. "In Reply to 'Role of Sodium Restriction in Recurrent Stone Formers With Hyperoxaluria'." American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, vol. 64, no. 3, 2014, pp. 478-9.
Noori N, Goldfarb DS, Basiri A. In reply to 'Role of sodium restriction in recurrent stone formers with hyperoxaluria'. Am J Kidney Dis. 2014;64(3):478-9.
Noori, N., Goldfarb, D. S., & Basiri, A. (2014). In reply to 'Role of sodium restriction in recurrent stone formers with hyperoxaluria'. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 64(3), 478-9. https://doi.org/10.1053/j.ajkd.2014.05.021
Noori N, Goldfarb DS, Basiri A. In Reply to 'Role of Sodium Restriction in Recurrent Stone Formers With Hyperoxaluria'. Am J Kidney Dis. 2014;64(3):478-9. PubMed PMID: 25150856.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - In reply to 'Role of sodium restriction in recurrent stone formers with hyperoxaluria'. AU - Noori,Nazanin, AU - Goldfarb,David S, AU - Basiri,Abbas, PY - 2014/05/28/received PY - 2014/05/30/accepted PY - 2014/8/25/entrez PY - 2014/8/26/pubmed PY - 2014/10/29/medline SP - 478 EP - 9 JF - American journal of kidney diseases : the official journal of the National Kidney Foundation JO - Am J Kidney Dis VL - 64 IS - 3 SN - 1523-6838 UR - https://www.unboundmedicine.com/medline/citation/25150856/In_reply_to_'Role_of_sodium_restriction_in_recurrent_stone_formers_with_hyperoxaluria'_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0272-6386(14)00982-2 DB - PRIME DP - Unbound Medicine ER -